PL1828196T3 - Stereoselektywny sposób wytwarzania i krystaliczne formy kamptotecyny - Google Patents

Stereoselektywny sposób wytwarzania i krystaliczne formy kamptotecyny

Info

Publication number
PL1828196T3
PL1828196T3 PL05849781T PL05849781T PL1828196T3 PL 1828196 T3 PL1828196 T3 PL 1828196T3 PL 05849781 T PL05849781 T PL 05849781T PL 05849781 T PL05849781 T PL 05849781T PL 1828196 T3 PL1828196 T3 PL 1828196T3
Authority
PL
Poland
Prior art keywords
camptothecin
crystalline forms
stereoselective process
stereoselective
crystalline
Prior art date
Application number
PL05849781T
Other languages
English (en)
Inventor
Paolo Carminati
Maria Ornella Tinti
Mauro Marzi
Fabrizio Giorgi
Walter Cabri
Marco Alpegiani
Domenico Vergani
Paolo Ghetti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PL1828196T3 publication Critical patent/PL1828196T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
PL05849781T 2004-12-21 2005-12-16 Stereoselektywny sposób wytwarzania i krystaliczne formy kamptotecyny PL1828196T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04030246 2004-12-21
PCT/EP2005/056849 WO2006067092A2 (en) 2004-12-21 2005-12-16 Stereoselective process and crystalline forms of a camptothecin
EP05849781A EP1828196B1 (en) 2004-12-21 2005-12-16 Stereoselective process and crystalline forms of a camptothecin

Publications (1)

Publication Number Publication Date
PL1828196T3 true PL1828196T3 (pl) 2013-02-28

Family

ID=34927884

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05849781T PL1828196T3 (pl) 2004-12-21 2005-12-16 Stereoselektywny sposób wytwarzania i krystaliczne formy kamptotecyny

Country Status (19)

Country Link
US (3) US7799921B2 (pl)
EP (1) EP1828196B1 (pl)
JP (2) JP5491699B2 (pl)
KR (1) KR101355121B1 (pl)
CN (1) CN101084221B (pl)
AU (1) AU2005318227B2 (pl)
BR (1) BRPI0515832A (pl)
CA (1) CA2590756C (pl)
CY (1) CY1117243T1 (pl)
DK (1) DK1828196T3 (pl)
ES (1) ES2395930T3 (pl)
HK (1) HK1113487A1 (pl)
HR (1) HRP20120926T1 (pl)
ME (1) ME01495B (pl)
PL (1) PL1828196T3 (pl)
PT (1) PT1828196E (pl)
RS (1) RS52585B (pl)
SI (1) SI1828196T1 (pl)
WO (1) WO2006067092A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2590756C (en) * 2004-12-21 2014-09-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Stereoselective process and crystalline forms of a camptothecin
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
FR2938534B1 (fr) 2008-11-14 2012-10-26 Sanofi Aventis Procede de preparation de l'hemifumarate d'eplivanserine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03271278A (ja) * 1990-03-16 1991-12-03 Nissan Chem Ind Ltd 2―アニリノピリミジン誘導体および農園芸用殺菌剤
JP3046401B2 (ja) * 1991-06-18 2000-05-29 イハラケミカル工業株式会社 6−〔1−(n−アルコキシイミノ)エチル〕サリチル酸誘導体及びその製造法
IL106786A (en) * 1992-09-10 1997-02-18 Basf Ag Substituted pyridine derivatives and fungicidal compositions containing them
EP1044977B1 (en) * 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity
MXPA04008484A (es) * 2002-03-01 2004-12-06 Pharmacia Italia Spa Forma polimorfica cristalina de clorhidrato de irinotecano.
CA2590756C (en) * 2004-12-21 2014-09-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Stereoselective process and crystalline forms of a camptothecin

Also Published As

Publication number Publication date
CN101084221A (zh) 2007-12-05
SI1828196T1 (sl) 2012-12-31
KR101355121B1 (ko) 2014-01-24
PT1828196E (pt) 2012-11-19
CY1117243T1 (el) 2017-04-05
US20100311783A1 (en) 2010-12-09
JP5491699B2 (ja) 2014-05-14
AU2005318227A1 (en) 2006-06-29
CA2590756C (en) 2014-09-02
CA2590756A1 (en) 2006-06-29
EP1828196B1 (en) 2012-10-17
CN101084221B (zh) 2011-05-11
US20090239893A1 (en) 2009-09-24
US8101758B2 (en) 2012-01-24
EP1828196A2 (en) 2007-09-05
WO2006067092A3 (en) 2006-11-02
KR20070097535A (ko) 2007-10-04
US7799921B2 (en) 2010-09-21
HK1113487A1 (en) 2008-10-03
JP2008524306A (ja) 2008-07-10
JP5982261B2 (ja) 2016-08-31
WO2006067092A2 (en) 2006-06-29
US8124769B2 (en) 2012-02-28
DK1828196T3 (da) 2012-11-26
JP2013067629A (ja) 2013-04-18
ME01495B (me) 2014-04-20
RS52585B (en) 2013-04-30
AU2005318227B2 (en) 2011-08-18
HRP20120926T1 (hr) 2012-12-31
US20100311784A1 (en) 2010-12-09
BRPI0515832A (pt) 2008-08-05
ES2395930T3 (es) 2013-02-18

Similar Documents

Publication Publication Date Title
PL378128A1 (pl) Sposób wytwarzania imatinibu i imatinib wytworzony tym sposobem
EP1788652A4 (en) FILM-PRODUCED ARTICLES AND METHOD OF MANUFACTURING THEREOF
HK1121497A1 (en) Production of tnfr-fc tnfr-fc
IL180742A0 (en) Method of manufacture
TWI367859B (en) Single crystalline diamond and producing method thereof
ZA200702585B (en) Hollow-bodled component and method for producing a component of this type
IL178064A0 (en) Chemical process and new crystalline form
EP1764416A4 (en) PROCESS FOR THE MANUFACTURE OF THEANIN
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
HK1113487A1 (en) Stereoselective process and crystalline forms of a camptothecin
ZA200704132B (en) Method of producing a carnitine-synthesising micro-organism
IL177649A0 (en) Method of preparing benzazepines and derivatives thereof
GB0423746D0 (en) Process and polymorphs prepared thereby
GB2431112B (en) Condom and production method thereof
EP1843780A4 (en) Methods of Treatment
IL180999A (en) Azo compounds and process for production thereof
GB0405465D0 (en) A cup and its method of production
HK1099931A1 (en) Synthesising method and benzoxathiepine intermediates
GB0405330D0 (en) Enzyme and preparation method
GB0516475D0 (en) A method of forming a structure and a structure
HUP0401841A2 (en) Combined micropropagating process and bioreactor
HU0400586D0 (en) Facing gacaparget and method of producing thereof
IL164580A0 (en) A method and means of bruting gemstones
ZA200406777B (en) Production of abalone
GB0413414D0 (en) Concrete and method of production thereof